1.2
Impact Factor
1.4
CiteScore
30 days
Time to First Decision

Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Hematology Reports, Volume 8, Issue 3

2016 September - 4 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (4)

Select all

Case Report

23 Citations

1,584 Views

4 Pages

Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab

Alexander G. Raufi,
Shruti Scott,
Omar Darwish,
Kevin Harley,
Kanwarpal Kahlon,
Sheetal Desai,
Yuxin Lu and
Minh-Ha Tran

Hematol. Rep.2016, 8(3), 6625;https://doi.org/10.4081/hr.2016.6625

30 September 2016

Among the spectrum of disease manifestations associated with systemic lupus erythematosus, lupus nephritis is particularly concerning due to the potential for renal failure. This autoimmune attack may not, however, be limited to the kidney and is inc...

Full Article

Case Report

5 Citations

847 Views

3 Pages

Positive Impact of Eculizumab Therapy on Surgery for Budd- Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Longterm History of Thrombosis

Silvia De-la-Iglesia,
Hugo Luzardo,
Angelina Lemes,
Melissa Torres,
Maria Teresa Gómez-Casares,
Naylen Cruz and
Teresa Molero

Hematol. Rep.2016, 8(3), 34-36;https://doi.org/10.4081/hr.2016.6562

30 September 2016

Paroxysmal nocturnal hemoglobinuria (PNH) is associated with severe end-organ damage and a high risk of thrombosis. Budd- Chiari syndrome, which develops after thrombotic occlusion of major hepatic blood vessels, is relatively common in PNH and has b...

Full Article

Case Report

1 Citations

634 Views

2 Pages

Brentuximab Vedotin Therapy for Cutaneous Lesions in T-prolymphocytic Leukemia: A Case Report

Jordan Senchak and
Peter Pickens

Hematol. Rep.2016, 8(3), 6593;https://doi.org/10.4081/hr.2016.6593

28 September 2016

We present an 88-year-old male with simultaneous T-cell prolymphocytic leukemia and stable smoldering myeloma with excellent initial response to three months of alemtuzumab. The patient relapsed at twelve months with severe cutaneous disease. Biopsy...

Full Article

Article

16 Citations

967 Views

5 Pages

GBT440 Inhibits Sickling of Sickle Cell Trait Blood under In Vitro Conditions Mimicking Strenuous Exercise

Kobina Dufu,
Josh Lehrer-Graiwer,
Eleanor Ramos and
Donna Oksenberg

Hematol. Rep.2016, 8(3), 6637;https://doi.org/10.4081/hr.2016.6637

28 September 2016

In sickle cell trait (SCT), hemoglobin A (HbA) and S (HbS) are co-expressed in each red blood cell (RBC). While homozygous expression of HbS (HbSS) leads to polymerization and sickling of RBCs resulting in sickle cell disease (SCD) characterized by h...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Hematol. Rep. - ISSN 2038-8330

Imprint

Download Flyer